These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 32832871)

  • 1. Conformational Changes in Tyrosine 11 of Neurotensin Are Required to Activate the Neurotensin Receptor 1.
    Bumbak F; Thomas T; Noonan-Williams BJ; Vaid TM; Yan F; Whitehead AR; Bruell S; Kocan M; Tan X; Johnson MA; Bathgate RAD; Chalmers DK; Gooley PR; Scott DJ
    ACS Pharmacol Transl Sci; 2020 Aug; 3(4):690-705. PubMed ID: 32832871
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Encounter Complexes Between the N-terminal of Neurotensin with the Extracellular Loop 2 of the Neurotensin Receptor 1 Steer Neurotensin to the Orthosteric Binding Pocket.
    Asadollahi K; Rajput S; Jameson GNL; Scott DJ; Gooley PR
    J Mol Biol; 2023 Oct; 435(20):168244. PubMed ID: 37625583
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure-based exploration of an allosteric binding pocket in the NTS1 receptor using bitopic NT(8-13) derivatives and molecular dynamics simulations.
    Kling RC; Burchardt C; Einsiedel J; Hübner H; Gmeiner P
    J Mol Model; 2019 Jun; 25(7):193. PubMed ID: 31209646
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thermostabilization of the neurotensin receptor NTS1.
    Shibata Y; White JF; Serrano-Vega MJ; Magnani F; Aloia AL; Grisshammer R; Tate CG
    J Mol Biol; 2009 Jul; 390(2):262-77. PubMed ID: 19422831
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimization and
    Bumbak F; Keen AC; Gunn NJ; Gooley PR; Bathgate RAD; Scott DJ
    Biochim Biophys Acta Biomembr; 2018 Jun; 1860(6):1372-1383. PubMed ID: 29596791
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurotensin Analogues Containing Cyclic Surrogates of Tyrosine at Position 11 Improve NTS2 Selectivity Leading to Analgesia without Hypotension and Hypothermia.
    Eiselt E; Gonzalez S; Martin C; Chartier M; Betti C; Longpré JM; Cavelier F; Tourwé D; Gendron L; Ballet S; Sarret P
    ACS Chem Neurosci; 2019 Nov; 10(11):4535-4544. PubMed ID: 31589400
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurotensin modulates the electrical activity of frog pituitary melanotropes via activation of a G-protein-coupled receptor pharmacologically related to both the NTS1 and nts2 receptors of mammals.
    Belmeguenai A; Vaudry H; Leprince J; Vivet B; Cavelier F; Martinez J; Louiset E
    Neuroendocrinology; 2000 Dec; 72(6):379-91. PubMed ID: 11146421
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HMC-1 human mast cells synthesize neurotensin (NT) precursor, secrete bioactive NT-like peptide(s) and express NT receptor NTS1.
    Cochrane DE; Carraway RE; Harrington K; Laudano M; Rawlings S; Feldberg RS
    Inflamm Res; 2011 Dec; 60(12):1139-51. PubMed ID: 21927981
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel stable analogues of the neurotensin C-terminal hexapeptide containing unnatural amino acids.
    Magafa V; Matsoukas MT; Karageorgos V; Dermitzaki E; Exarchakou R; Stylos EΚ; Pardalos M; Margioris AN; Varvounis G; Tzakos AG; Spyroulias GA; Liapakis G
    Amino Acids; 2019 Jul; 51(7):1009-1022. PubMed ID: 31079216
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of Molecular Modeling to Design Selective NTS2 Neurotensin Analogues.
    Fanelli R; Floquet N; Besserer-Offroy É; Delort B; Vivancos M; Longpré JM; Renault P; Martinez J; Sarret P; Cavelier F
    J Med Chem; 2017 Apr; 60(8):3303-3313. PubMed ID: 28368584
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NTS1 and NTS2 mediate analgesia following neurotensin analog treatment in a mouse model for visceral pain.
    Smith KE; Boules M; Williams K; Richelson E
    Behav Brain Res; 2012 Jun; 232(1):93-7. PubMed ID: 22504145
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of polyphenols on receptor-ligand interactions by NMR: the case of neurotensin (NT)-neurotensin receptor fragment (NTS1) complex.
    Richard T; Petit E; Pouységu L; Monti JP; Bondon A; Sylla T; Mérillon JM; Quideau S; Da Costa G
    J Biomol Struct Dyn; 2020 Mar; 38(5):1467-1478. PubMed ID: 31046599
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bidirectional regulation of dopamine D2 and neurotensin NTS1 receptors in dopamine neurons.
    Jomphe C; Lemelin PL; Okano H; Kobayashi K; Trudeau LE
    Eur J Neurosci; 2006 Nov; 24(10):2789-800. PubMed ID: 17116165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Label-free cell phenotypic profiling and pathway deconvolution of neurotensin receptor-1.
    Hou T; Shi L; Wang J; Wei L; Qu L; Zhang X; Liang X
    Pharmacol Res; 2016 Jun; 108():39-45. PubMed ID: 27117668
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insightful Backbone Modifications Preventing Proteolytic Degradation of Neurotensin Analogs Improve NT
    Previti S; Vivancos M; Rémond E; Beaulieu S; Longpré JM; Ballet S; Sarret P; Cavelier F
    Front Chem; 2020; 8():406. PubMed ID: 32582624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Over-expression of neurotensin high-affinity receptor 1 (NTS1) in relation with its ligand neurotensin (NT) and nuclear beta-catenin in inflammatory bowel disease-related oncogenesis.
    Bossard C; Souazé F; Jarry A; Bezieau S; Mosnier JF; Forgez P; Laboisse CL
    Peptides; 2007 Oct; 28(10):2030-5. PubMed ID: 17870207
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurotensin receptors inhibit mGluR I responses in nigral dopaminergic neurons via a process that undergoes functional desensitization by G-protein coupled receptor kinases.
    Martini A; Cordella A; Pisani A; Mercuri NB; Guatteo E
    Neuropharmacology; 2019 Sep; 155():76-88. PubMed ID: 31128122
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurotensin modulates central muscarinic receptors, an effect which does not involve the high-affinity neurotensin receptor (NTS1).
    Schneider PG; López Ordieres MG; Rodríguez de Lores Arnaiz G
    Regul Pept; 2010 Aug; 163(1-3):37-42. PubMed ID: 20403392
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular and cellular regulation of neurotensin receptor under acute and chronic agonist stimulation.
    Souazé F; Forgez P
    Peptides; 2006 Oct; 27(10):2493-501. PubMed ID: 16889873
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyperactivity of the dopaminergic system in NTS1 and NTS2 null mice.
    Liang Y; Boules M; Li Z; Williams K; Miura T; Oliveros A; Richelson E
    Neuropharmacology; 2010 Jun; 58(8):1199-205. PubMed ID: 20211191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.